When was Hubei Changjiang Pharmaceutical Group listed on the main board?

Changjiang Medicine successfully landed on the New Third Board on August 8, 2006, with a market value of nearly 4 billion yuan. At present, Changjiang Medicine is actively preparing for listing. Changjiang Medicine's achievements in industrial poverty alleviation and financial poverty alleviation have been highly recognized by the CSRC, and as an advanced model of poverty alleviation work of the CSRC, it gives priority to listing counseling.

Extended data:

First, the listing conditions of the New Third Board:

1, which satisfies the condition that the New Third Board exists for two years. (The overall restructuring of a limited company can be calculated continuously);

2. The main business of the New Third Board is outstanding and it has a record of going concern; Conditions that must be met.

3. The NEEQ listed companies have sound governance structure and standardized operating conditions;

4. The issuance and transfer of shares of listed companies on the New Third Board are legal and compliant;

5. The registered address of the new third board listed company is in the pilot national high-tech park;

6. The local government issued a confirmation letter for the pilot qualification of listing the New Third Board.

Second, the listing of the New Third Board needs to meet the following requirements:

1, main qualification listing requirements: the companies listed on the New Third Board must be unlisted joint-stock companies.

2. Operation life requirement: the duration must be two years.

3. Profitability requirements of the companies listed on the New Third Board: They must have stable and continuous operation ability.

4. Asset requirements: unlimited.

5. Main business requirements: The main business must be prominent.

6. Requirements for growth and innovation ability: Zhongguancun high-tech enterprises will gradually expand the pilot scope to other high-tech industrial development zones.